India-based Ansa Folding Carton (AFC) has expanded its operations by acquiring a strategic stake in paper packaging material producer Rich Printers. 

The deal, valued at Rs1.17bn ($14.04m), positions the combined entity as the largest pharmaceutical folding carton producer in India, with a total of five paper conversion manufacturing plants. 

With a network of three advanced manufacturing facilities, Rich Printers is a producer of folding cartons for the pharmaceutical industry.

The new entity expects to have a paper conversion capacity of 40,000 tons (t) for next year, with plans to double its size in the forthcoming years. 

It is set to operate nine facilities across key Indian states, including Gujarat, Maharashtra, Himachal Pradesh, Sikkim, and West Bengal.  

In a joint statement, Rich Printers directors Tushar Shah and Nayan Shah said: “Rich Group is excited to join hands with the Ansapack family. We at Rich have had a heritage of serving our customers in the folding carton manufacturing space and see parallels with AFC who have had a similar longstanding reputation.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“AFC’s deep understanding of the domestic market, their vision of sustainable growth, and other complimentary business verticals in the pharma packaging space within the group, make them the clear choice for partnering.”